Literature DB >> 23636801

The expression of glutamine-metabolism-related proteins in breast phyllodes tumors.

Sewha Kim1, Woo Hee Jung, Ja Seung Koo.   

Abstract

The aim of this study was to investigate the expression of glutamine-metabolism-related proteins according to the histologic grade of phyllodes tumors (PTs) and to assess its clinical implication. We generated tissue microarrays of 224 PTs and performed immunohistochemical staining and western blot analysis of glutamine-metabolism-related molecules, including GLS1, GDH, and ASCT2. The associations between immunohistochemical results and clinicopathologic parameters were evaluated. The expression of GLS1 (p < 0.001), GDH (p < 0.001), and ASCT2 (p = 0.005) in stromal components significantly increased with worsening PT histological grade. GDH expression in epithelial components significantly increased in high-grade PT (p = 0.026). In western blot, stromal expression of GLS1, GDH, and ASCT2 increased as histologic grade increased. By univariate analysis, stromal GLS1 expression (p = 0.022) and stromal GDH expression (p = 0.009) were independent predictors of shorter DFS. Stromal GLS1 expression (p < 0.001) and stromal GDH expression (p < 0.001) were independent predictors of shorter OS. This study demonstrated that the stromal expression of the glutamine-metabolism-related proteins GLS1, GDH, ASCT2 increases with worsening histological PT grade.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23636801     DOI: 10.1007/s13277-013-0819-7

Source DB:  PubMed          Journal:  Tumour Biol        ISSN: 1010-4283


  23 in total

1.  On the origin of cancer cells.

Authors:  O WARBURG
Journal:  Science       Date:  1956-02-24       Impact factor: 47.728

2.  Forskolin photoaffinity labels with specificity for adenylyl cyclase and the glucose transporter.

Authors:  D I Morris; J D Robbins; A E Ruoho; E M Sutkowski; K B Seamon
Journal:  J Biol Chem       Date:  1991-07-15       Impact factor: 5.157

3.  Glutaminolysis and glycolysis regulation by troglitazone in breast cancer cells: Relationship to mitochondrial membrane potential.

Authors:  Ellen Friday; Robert Oliver; Tomas Welbourne; Francesco Turturro
Journal:  J Cell Physiol       Date:  2011-02       Impact factor: 6.384

4.  Measurement of glut-1 expression using tissue microarrays to determine a race specific prognostic marker for breast cancer.

Authors:  Bodiford Lee Stackhouse; Holly Williams; Paul Berry; Greg Russell; Pamela Thompson; Jerald L Winter; Timothy Kute
Journal:  Breast Cancer Res Treat       Date:  2005-10       Impact factor: 4.872

5.  GLUT1 expression in human breast carcinoma: correlation with known prognostic markers.

Authors:  M Younes; R W Brown; D R Mody; L Fernandez; R Laucirica
Journal:  Anticancer Res       Date:  1995 Nov-Dec       Impact factor: 2.480

6.  Differential expression of Glut 1 mRNA and protein levels correlates with increased sensitivity to the glyco-conjugated nitric oxide donor (2-glu-SNAP) in different tumor cell types.

Authors:  P R Subbarayan; P G Wang; T J Lampidis; B Ardalan; P Braunschweiger
Journal:  J Chemother       Date:  2008-02       Impact factor: 1.714

7.  c-Myc suppression of miR-23a/b enhances mitochondrial glutaminase expression and glutamine metabolism.

Authors:  Ping Gao; Irina Tchernyshyov; Tsung-Cheng Chang; Yun-Sil Lee; Kayoko Kita; Takafumi Ochi; Karen I Zeller; Angelo M De Marzo; Jennifer E Van Eyk; Joshua T Mendell; Chi V Dang
Journal:  Nature       Date:  2009-02-15       Impact factor: 49.962

Review 8.  Q's next: the diverse functions of glutamine in metabolism, cell biology and cancer.

Authors:  R J DeBerardinis; T Cheng
Journal:  Oncogene       Date:  2009-11-02       Impact factor: 9.867

9.  Clonal analysis of fibroadenoma and phyllodes tumor of the breast.

Authors:  S Noguchi; K Motomura; H Inaji; S Imaoka; H Koyama
Journal:  Cancer Res       Date:  1993-09-01       Impact factor: 12.701

10.  Overexpression of Glut-1 glucose transporter in human breast cancer. An immunohistochemical study.

Authors:  R S Brown; R L Wahl
Journal:  Cancer       Date:  1993-11-15       Impact factor: 6.860

View more
  9 in total

1.  Expression of serine/glycine metabolism-related proteins is different according to the thyroid cancer subtype.

Authors:  Woo Young Sun; Hye Min Kim; Woo-Hee Jung; Ja Seung Koo
Journal:  J Transl Med       Date:  2016-06-08       Impact factor: 5.531

2.  Benzylserine inhibits breast cancer cell growth by disrupting intracellular amino acid homeostasis and triggering amino acid response pathways.

Authors:  Michelle van Geldermalsen; Lake-Ee Quek; Nigel Turner; Natasha Freidman; Angel Pang; Yi Fang Guan; James R Krycer; Renae Ryan; Qian Wang; Jeff Holst
Journal:  BMC Cancer       Date:  2018-06-26       Impact factor: 4.430

3.  Novel alanine serine cysteine transporter 2 (ASCT2) inhibitors based on sulfonamide and sulfonic acid ester scaffolds.

Authors:  Elias Ndaru; Rachel-Ann A Garibsingh; YueYue Shi; Evan Wallace; Paul Zakrepine; Jiali Wang; Avner Schlessinger; Christof Grewer
Journal:  J Gen Physiol       Date:  2019-02-04       Impact factor: 4.086

Review 4.  Metabolic reprogramming and its clinical application in thyroid cancer.

Authors:  Shi-Shuai Wen; Ting-Ting Zhang; Di-Xin Xue; Wei-Li Wu; Yu-Long Wang; Yu Wang; Qing-Hai Ji; Yong-Xue Zhu; Ning Qu; Rong-Liang Shi
Journal:  Oncol Lett       Date:  2019-06-18       Impact factor: 2.967

5.  GLUT1 and ASCT2 Protein Expression in Papillary Thyroid Carcinoma Patients and Relation to Hepatitis C Virus: A Propensity-Score Matched Analysis.

Authors:  Afaf T Ibrahiem; Manal S Fawzy; Jawaher A Abdulhakim; Eman A Toraih
Journal:  Int J Gen Med       Date:  2022-03-14

6.  Glutamine addiction promotes glucose oxidation in triple-negative breast cancer.

Authors:  Lake-Ee Quek; Michelle van Geldermalsen; Yi Fang Guan; Kanu Wahi; Chelsea Mayoh; Seher Balaban; Angel Pang; Qian Wang; Mark J Cowley; Kristin K Brown; Nigel Turner; Andrew J Hoy; Jeff Holst
Journal:  Oncogene       Date:  2022-07-18       Impact factor: 8.756

7.  Interaction of the neutral amino acid transporter ASCT2 with basic amino acids.

Authors:  Elias Ndaru; Rachel-Ann A Garibsingh; Laura Zielewicz; Avner Schlessinger; Christof Grewer
Journal:  Biochem J       Date:  2020-04-30       Impact factor: 3.766

8.  High expression of Solute Carrier Family 1, member 5 (SLC1A5) is associated with poor prognosis in clear-cell renal cell carcinoma.

Authors:  Yidong Liu; Liu Yang; Huimin An; Yuan Chang; Weijuan Zhang; Yu Zhu; Le Xu; Jiejie Xu
Journal:  Sci Rep       Date:  2015-11-24       Impact factor: 4.379

9.  Expression of glutamine metabolism-related proteins in thyroid cancer.

Authors:  Hye Min Kim; Yu Kyung Lee; Ja Seung Koo
Journal:  Oncotarget       Date:  2016-08-16
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.